- Docket No.
- 0:23-cv-02024
- District Court
- Minnesota
Goal
- Block enforcement of a law
- Declaration that a law is unlawful
Issues
Case History
Litigation Content
Why this Matters
The plaintiff argues that a Minnesota law prohibiting generic drug manufacturers from excessively increasing prices violates the Due Process Clause of the Fourteenth Amendment, the Dormant Commerce Clause, and the separation of powers principle. Price gouging laws are one approach states are currently pursuing to lower prescription drug costs for their residents.
Potential Impact
The inability for state policymakers to address prescription drug affordability could negate savings for patients, and more broadly restrict state regulatory authority in the health care arena.
News And Analysis (1)
18 Major Filings
- JOINT STATUS REPORT (Nov 6, 2025)
- APPELLATE MANDATE (Aug 8, 2025)
- APPELLATE JUDGMENT (Jun 12, 2025)
- APPELLATE OPINION (Jun 12, 2025)
- ORDER ON MOTION FOR STAY (Jan 4, 2024)
- JOINT MOTION FOR STAY (Jan 4, 2024)
- DEFENDANT'S NOTICE OF APPEAL (Jan 2, 2024)
- JUDGMENT (Dec 4, 2023)
- ORDER ON MOTION FOR PRELIMINARY INJUNCTION AND MOTION TO DISMISS (Dec 4, 2023)
- DEFENDANT'S REPLY RE: MOTION TO DISMISS (Aug 23, 2023)
- PLAINTIFF'S REPLY RE: MOTION FOR PRELIMINARY INJUNCTION AND RESPONSE TO MOTION TO DISMISS (Aug 11, 2023)
- DECLARATION OF KATRINA HOWARD (Jul 31, 2023)
- DECLARATION OF NOAH LEWELLEN (Jul 31, 2023)
- DECLARATION OF RANDALL ARMBRUSTER (Jul 31, 2023)
- DEFENDANT'S MOTION TO DISMISS (Jul 31, 2023)
- PLAINTIFF'S MEMORANDUM RE: MOTION FOR PRELIMINARY INJUNCTION (Jul 19, 2023)
- PLAINTIFF'S MOTION FOR PRELIMINARY INJUNCTION (Jul 19, 2023)
- COMPLAINT (Jul 5, 2023)